Literature DB >> 32386598

Response to letter regarding article "Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease".

Matthew R Weir1, Veronica Ashton2, Kenneth T Moore3, Shubham Shrivastava4, Eric D Peterson5, Eric M Ammann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32386598     DOI： 10.1016/j.ahj.2020.03.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  1 in total

1.  Plasma Rivaroxaban Level in Patients With Early Stages of Chronic Kidney Disease-Relationships With Renal Function and Clinical Events.

Authors:  Chun-Fung Sin; Ka-Ping Wong; Hoi-Man Wong; Chung-Wah Siu; Desmond Y H Yap
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.